Arlington Trust’s Medifast MED Stock Holding History

Arlington Trust’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15	Closed	-$1.01K	–	729
2023 Q4	$1.01K	Buy	+15	New	+$1.04K	﹤0.01%	827

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Arlington Trust's MED Position: Q1 2024 in Review

Arlington Trust sold out of Medifast (MED) in Q1 2024, closing a stake of 15 shares — an estimated $1.01K sold.

Arlington Trust first reported a position in MED in Q4 2023 and held it in 1 quarter. The position peaked at $1.01K in Q4 2023. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

Arlington Trust reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
Arlington Trust sold 15 Medifast shares in Q1 2024, an estimated $1.01K.
Arlington Trust first reported a position in Medifast in Q4 2023 and held it in 1 quarter.
Arlington Trust's Medifast position peaked at $1.01K in Q4 2023.
186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Arlington Trust's 13F filing for Q1 2024, filed 16 Apr 2024.